These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20496311)

  • 21. Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide.
    van der Vlist A; Snijders TJ; Stades AME; Spliet WGM; De Vos FYFL
    Neth J Med; 2017 Dec; 75(10):451-454. PubMed ID: 29256415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.
    Batista DL; Zhang X; Gejman R; Ansell PJ; Zhou Y; Johnson SA; Swearingen B; Hedley-Whyte ET; Stratakis CA; Klibanski A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4482-8. PubMed ID: 16940446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy.
    Hagen C; Schroeder HD; Hansen S; Hagen C; Andersen M
    Eur J Endocrinol; 2009 Oct; 161(4):631-7. PubMed ID: 19654234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date.
    Chen C; Yin S; Zhang S; Wang M; Hu Y; Zhou P; Jiang S
    Medicine (Baltimore); 2017 Nov; 96(47):e8733. PubMed ID: 29381964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temozolomide in aggressive pituitary adenomas and carcinomas.
    Ortiz LD; Syro LV; Scheithauer BW; Rotondo F; Uribe H; Fadul CE; Horvath E; Kovacs K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):119-23. PubMed ID: 22584716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.
    Kamiya-Matsuoka C; Cachia D; Waguespack SG; Crane CH; Mahajan A; Brown PD; Nam JY; McCutcheon IE; Penas-Prado M
    Pituitary; 2016 Aug; 19(4):415-21. PubMed ID: 27106209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octreotide and the novel multireceptor ligand somatostatin receptor agonist pasireotide (SOM230) block the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary.
    Nolan LA; Schmid HA; Levy A
    Endocrinology; 2007 Jun; 148(6):2821-7. PubMed ID: 17347306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of temozolomide in aggressive pituitary tumors: case report.
    Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD
    Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Nelson's syndrome with temozolomide.
    Moyes VJ; Alusi G; Sabin HI; Evanson J; Berney DM; Kovacs K; Monson JP; Plowman PN; Drake WM
    Eur J Endocrinol; 2009 Jan; 160(1):115-9. PubMed ID: 18984772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings.
    Kovacs K; Horvath E; Syro LV; Uribe H; Penagos LC; Ortiz LD; Fadul CE
    Hum Pathol; 2007 Jan; 38(1):185-9. PubMed ID: 17056093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of pituitary neoplasms with temozolomide: A review.
    Marucci G
    Cancer; 2011 Sep; 117(17):4101-2; author reply 4102. PubMed ID: 21387270
    [No Abstract]   [Full Text] [Related]  

  • 32. Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management.
    Zhong C; Yin S; Zhou P; Jiang S
    Turk Neurosurg; 2014; 24(6):963-6. PubMed ID: 25448217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide.
    Felker J; Patterson B; Wrubel D; Janss A
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1413-1415. PubMed ID: 27815961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temozolomide and pituitary adenoma.
    Hueng DY; Ma HI; Sytwu HK; Liu MY
    J Neurosurg; 2011 Jun; 114(6):1820: author reply 1820-1. PubMed ID: 21513431
    [No Abstract]   [Full Text] [Related]  

  • 36. Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
    Dillard TH; Gultekin SH; Delashaw JB; Yedinak CG; Neuwelt EA; Fleseriu M
    Pituitary; 2011 Mar; 14(1):80-91. PubMed ID: 20972839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.
    Katznelson L
    J Clin Endocrinol Metab; 2013 May; 98(5):1803-7. PubMed ID: 23539733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
    Mendola M; Passeri E; Ambrosi B; Corbetta S
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2623-4. PubMed ID: 24823463
    [No Abstract]   [Full Text] [Related]  

  • 39. SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
    Fedele M; De Martino I; Pivonello R; Ciarmiello A; Del Basso De Caro ML; Visone R; Palmieri D; Pierantoni GM; Arra C; Schmid HA; Hofland L; Lombardi G; Colao A; Fusco A
    Clin Cancer Res; 2007 May; 13(9):2738-44. PubMed ID: 17473207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review.
    Almalki MH; Aljoaib NN; Alotaibi MJ; Aldabas BS; Wahedi TS; Ahmad MM; Alshahrani F
    Hormones (Athens); 2017 Apr; 16(2):139-149. PubMed ID: 28742502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.